By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087



Company News
Aerie (AERI) To Participate In Several Conferences In November 11/5/2015 12:54:34 PM
Aerie (AERI) Reports Third Quarter 2015 Financial Results And Provides Business Update 11/4/2015 11:14:28 AM
Aerie (AERI) To Host Investor And Media Briefing During The 2015 American Academy of Ophthalmology Annual Meeting On November 13, 2015 11/4/2015 10:58:31 AM
Aerie (AERI) To Announce Third Quarter 2015 Financial Results And Host Conference Call On Tuesday, November 3, 2015 10/20/2015 10:49:25 AM
Aerie (AERI) Initiates Fourth Phase III Clinical Trial of Rhopressa 9/24/2015 11:22:08 AM
Aerie (AERI) Initiates First Phase III Registration Trial Of Roclatan 9/21/2015 11:28:19 AM
Aerie (AERI) Shares Soar After Glaucoma Drug Meets Late Stage Endpoints 9/17/2015 6:38:31 AM
Aerie (AERI) Announces That Richard A. Lewis, M.D., Has Joined As Chief Medical Officer 9/9/2015 10:50:03 AM
Aerie (AERI) And Ramot At Tel Aviv University Enter Research Collaboration 9/9/2015 9:42:51 AM
Aerie (AERI) To Present At The Canaccord Genuity Growth Conference 8/6/2015 12:22:01 PM